These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34811955)

  • 41. Esomeprazole MUPS 40 mg tablets and esomeprazole MUPS 40 mg tablets encapsulated in hard gelatine are bioequivalent.
    Talpes S; Knoerzer D; Huber R; Pfaffenberger B
    Int J Clin Pharmacol Ther; 2005 Jan; 43(1):51-6. PubMed ID: 15704615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of esomeprazole, a proton pump inhibitor on the pharmacokinetics of sonidegib in healthy volunteers.
    Zhou J; Quinlan M; Glenn K; Boss H; Picard F; Castro H; Sellami D
    Br J Clin Pharmacol; 2016 Oct; 82(4):1022-9. PubMed ID: 27277189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
    Navratilova E; Behravesh S; Oyarzo J; Dodick DW; Banerjee P; Porreca F
    Cephalalgia; 2020 Aug; 40(9):892-902. PubMed ID: 32615788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults.
    Min KC; Kraft WK; Bondiskey P; Colón-González F; Liu W; Xu J; Panebianco D; Mixson L; Dockendorf MF; Matthews CZ; Boinpally R
    Clin Transl Sci; 2021 Mar; 14(2):599-605. PubMed ID: 33142014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis.
    Johnston K; Popoff E; Deighton A; Dabirvaziri P; Harris L; Thiry A; Croop R; Coric V; L'Italien G; Moren J
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jan; 22(1):155-166. PubMed ID: 34148501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic study of esomeprazole in the elderly.
    Hasselgren G; Hassan-Alin M; Andersson T; Claar-Nilsson C; Röhss K
    Clin Pharmacokinet; 2001; 40(2):145-50. PubMed ID: 11286324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Efficacy and Safety of Ubrogepant for the Acute Treatment of Migraine.
    Dodick DW; Ailani J
    J Fam Pract; 2020; 69(1 Suppl):S13-S22. PubMed ID: 32053715
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of ubrogepant for migraine: a meta-analysis of randomized controlled studies.
    Wu SZ; Chen L
    Int J Neurosci; 2024 Jun; 134(2):124-130. PubMed ID: 35999672
    [No Abstract]   [Full Text] [Related]  

  • 50. Newer Horizon for Treatment of Acute Attack of Migraine: Lasmiditan and Ubrogepant.
    Maitra A; Mukhopadhyay S; Das A; Choudhury S
    Neurol India; 2021; 69(6):1759-1762. PubMed ID: 34979683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic study of esomeprazole in patients with hepatic impairment.
    Sjövall H; Björnsson E; Holmberg J; Hasselgren G; Röhss K; Hassan-Alin M
    Eur J Gastroenterol Hepatol; 2002 May; 14(5):491-6. PubMed ID: 11984146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel Therapies in Acute Migraine Management: Small-Molecule Calcitonin Gene-Receptor Antagonists and Serotonin 1F Receptor Agonist.
    Joyner KR; Morgan KW
    Ann Pharmacother; 2021 Jun; 55(6):745-759. PubMed ID: 32993366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics.
    Shimizu T; Nakayama Y; Ishii E; Ida S; Satou T; Tokuhara D; Arai K; Nii M; Rydholm H; Yajima T;
    Pediatr Int; 2019 Jan; 61(1):87-95. PubMed ID: 30422368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treating acute migraine with ubrogepant.
    Schoenfuss ES
    JAAPA; 2023 Sep; 36(9):25-28. PubMed ID: 37668477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An open-label investigation of the pharmacokinetic profiles of lisdexamfetamine dimesylate and venlafaxine extended-release, administered alone and in combination, in healthy adults.
    Ermer J; Haffey MB; Richards C; Lasseter K; Roesch B; Purkayastha J; Corcoran M; Harlin B; Martin P
    Clin Drug Investig; 2013 Apr; 33(4):243-54. PubMed ID: 23512639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioequivalence of two esomeprazole magnesium enteric-coated formulations in healthy Chinese subjects.
    Liu ZZ; Ren Q; Zhou YN; Yang HM
    World J Clin Cases; 2020 Nov; 8(22):5518-5528. PubMed ID: 33344542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs.
    Hwang JH; Jeong JW; Song GH; Koo TS; Seo KW
    J Vet Intern Med; 2017 May; 31(3):743-750. PubMed ID: 28407418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atogepant and sumatriptan: no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial.
    Boinpally R; Jakate A; Butler M; Periclou A
    Pain Manag; 2022 May; 12(4):499-508. PubMed ID: 34898273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.